ER (Estrogen Receptor)
27 drugsPredictive biomarker for patient selection in 16 indications
27
Approved Drugs
16
Indications
22
Companies
ER (Estrogen Receptor) is a precision-medicine biomarker linked to 27 FDA-approved targeted drugs from 22 companies, spanning 16 indications including Osteoporosis, Breast Cancer, Vasomotor Symptoms. Explore the targeted therapies, indications, testing methods, and companies developing ER (Estrogen Receptor) drugs below.
Search ER (Estrogen Receptor) Clinical Trials
Search recruiting trials on ClinicalTrials.gov
Drugs Targeting ER (Estrogen Receptor)
| Drug | Company | Therapeutic Area |
|---|---|---|
| ACTIVELLA | Novo Nordisk | Women's Health |
| ANGELIQ | Bayer | Women's Health |
| BIJUVA | MAYNE PHARMA | Women's Health |
| CLIMARA | Bayer | Women's Health |
| CLIMARA PRO | BERLEX LABS | Women's Health |
| CONJUGATED ESTROGENS | NOVAST LABS | Oncology |
| DIVIGEL | VERTICAL PHARMS | Women's Health |
| ELESTRIN | Viatris | Women's Health |
| ESTRADIOL AND NORETHINDRONE ACETATE | NOVAST LABS | Women's Health |
| ESTROGEL | ASCEND THERAPS US | Women's Health |
| EVAMIST | PADAGIS US | Women's Health |
| EVISTA | Eli Lilly | Oncology |
| FASLODEX | AstraZeneca | Oncology |
| FEMRING | MILLICENT MFG PR | Women's Health |
| FULVESTRANT | SAGENT PHARMS INC | Oncology |
| FYAVOLV | Lupin | Women's Health |
| IMVEXXY | MAYNE PHARMA | Women's Health |
| MENOSTAR | Bayer | Women's Health |
| MINIVELLE | NOVEN | Women's Health |
| MYFEMBREE | SUMITOMO PHARMA AM | Women's Health |
| OSPHENA | DUCHESNAY | Women's Health |
| PREMPHASE 14/14 | Pfizer | Oncology |
| PREMPRO | Pfizer | Women's Health |
| RALOXIFENE HYDROCHLORIDE | SCIEGEN PHARMS | Oncology |
| SOLTAMOX | MAYNE PHARMA COMMRCL | Oncology |
| TOREMIFENE CITRATE | MSN | Oncology |
| VIVELLE-DOT | Novartis | Women's Health |
ER (Estrogen Receptor) Indications
Osteoporosis Breast Cancer Vasomotor Symptoms Vulvar and Vaginal Atrophy Hypoestrogenism Hypogonadism Primary Ovarian Failure Postmenopausal Osteoporosis Dyspareunia Vaginal Dryness Prostate Cancer Metastatic Breast Cancer Ductal Carcinoma in Situ Heavy Menstrual Bleeding Uterine Leiomyoma Endometriosis